151 related articles for article (PubMed ID: 17933798)
1. Is protection by inhalation agents volatile? Controversies in cardioprotection.
Zaugg M
Br J Anaesth; 2007 Nov; 99(5):603-6. PubMed ID: 17933798
[No Abstract] [Full Text] [Related]
2. Sevoflurane and cardioprotection.
Siracusano L; Girasole V
Br J Anaesth; 2008 Feb; 100(2):278; author reply 278-9. PubMed ID: 18212000
[No Abstract] [Full Text] [Related]
3. Pharmacological preconditioning of the heart during surgery.
Landoni G; Figini F; Bignami E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):982-3; author reply 983. PubMed ID: 19853466
[No Abstract] [Full Text] [Related]
4. Anaesthesia and myocardial ischaemia/reperfusion injury.
Frässdorf J; De Hert S; Schlack W
Br J Anaesth; 2009 Jul; 103(1):89-98. PubMed ID: 19502287
[TBL] [Abstract][Full Text] [Related]
5. Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial.
Piriou V; Mantz J; Goldfarb G; Kitakaze M; Chiari P; Paquin S; Cornu C; Lecharny JB; Aussage P; Vicaut E; Pons A; Lehot JJ
Br J Anaesth; 2007 Nov; 99(5):624-31. PubMed ID: 17913754
[TBL] [Abstract][Full Text] [Related]
6. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.
De Hert S; Vlasselaers D; Barbé R; Ory JP; Dekegel D; Donnadonni R; Demeere JL; Mulier J; Wouters P
Anaesthesia; 2009 Sep; 64(9):953-60. PubMed ID: 19686479
[TBL] [Abstract][Full Text] [Related]
7. Physiology and pharmacology of myocardial preconditioning.
Raphael J
Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):54-9. PubMed ID: 20472628
[TBL] [Abstract][Full Text] [Related]
8. From coronary steal to myocardial, renal, and cerebral protection: more questions than answers in anaesthetic preconditioning?
Kunst G
Br J Anaesth; 2014 Jun; 112(6):958-60. PubMed ID: 24574506
[No Abstract] [Full Text] [Related]
9. Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty?
Pagel PS
J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):589-93. PubMed ID: 19789055
[No Abstract] [Full Text] [Related]
10. Cardioprotection with volatile anesthetics: mechanisms and clinical implications.
De Hert SG; Turani F; Mathur S; Stowe DF
Anesth Analg; 2005 Jun; 100(6):1584-1593. PubMed ID: 15920178
[TBL] [Abstract][Full Text] [Related]
11. Volatile anaesthetics and cardioprotection: lessons from animal studies.
Muntean DM; Ordodi V; Ferrera R; Angoulvant D
Fundam Clin Pharmacol; 2013 Feb; 27(1):21-34. PubMed ID: 22804787
[TBL] [Abstract][Full Text] [Related]
12. Con: Ischemic preconditioning is not necessary because volatile agents accomplish it.
Piriou V; Chiari P
J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):803-5. PubMed ID: 15650998
[No Abstract] [Full Text] [Related]
13. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients.
Huang Z; Zhong X; Irwin MG; Ji S; Wong GT; Liu Y; Xia ZY; Finegan BA; Xia Z
Clin Sci (Lond); 2011 Jul; 121(2):57-69. PubMed ID: 21291422
[TBL] [Abstract][Full Text] [Related]
14. Delayed cardioprotection by inhaled anesthetics.
Pagel PS; Hudetz JA
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1125-40. PubMed ID: 21109464
[No Abstract] [Full Text] [Related]
15. Cardioprotection by volatile anesthetics.
Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
[TBL] [Abstract][Full Text] [Related]
16. β-blockers and volatile anesthetics may attenuate cardioprotection by remote preconditioning in adult cardiac surgery: a meta-analysis of 15 randomized trials.
Zhou C; Liu Y; Yao Y; Zhou S; Fang N; Wang W; Li L
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):305-11. PubMed ID: 23276595
[TBL] [Abstract][Full Text] [Related]
17. Myocardial protection by volatile anesthetics in patients undergoing cardiac surgery: a critical review of the laboratory and clinical evidence.
Pagel PS
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):972-82. PubMed ID: 23623887
[No Abstract] [Full Text] [Related]
18. Role of nuclear factor-κB in volatile anaesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion.
Wang C; Xie H; Liu X; Qin Q; Wu X; Liu H; Liu C
Eur J Anaesthesiol; 2010 Aug; 27(8):747-56. PubMed ID: 20601888
[TBL] [Abstract][Full Text] [Related]
19. Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.
Kunst G; Klein AA
Anaesthesia; 2015 Apr; 70(4):467-82. PubMed ID: 25764404
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
